A very interesting new article on senolytic treatment potential for Long COVID has recently been published in the Nature Aging journal.
“Our findings therefore suggest a detrimental role for virus-induced senescence in acceleration of brain inflammation…a potential therapeutic role for senolytics in the treatment of COVID-19 neuropathology.”